A spot can look harmless at breakfast and worrying by dinner once you notice its uneven colour or a crust that keeps returning. In the decision between biopsy versus monitoring, the aim is not to cause alarm or remove every mole. It is to identify the lesions that need a definite answer before valuable time is lost.

For Australians, this question carries real weight. Our high UV exposure means skin cancer is common, and early diagnosis can make a major difference to treatment. A trained clinician may be able to reassure you that a lesion is benign, recommend close photographic monitoring, or advise a biopsy. Each pathway has a purpose. The right choice depends on the lesion, your personal risk and whether it can be assessed safely without delay.

Biopsy versus monitoring: the essential difference

A biopsy means taking some or all of a skin lesion and sending it to a laboratory for examination under a microscope. A pathologist examines the cells and provides the diagnosis. For a suspicious lesion, this is the most reliable way to determine whether cancer is present and, if it is, what type it is.

Monitoring means recording the appearance of a lesion and reviewing it over time. This may involve clinical photographs, dermoscopic images taken with a specialised magnifying device, measurements and a planned follow-up appointment. Monitoring is not simply being told to “keep an eye on it” at home. When it is used appropriately, it is a structured clinical plan with a clear review timeframe.

Neither option is automatically better. A biopsy provides certainty but leaves a wound and usually a small scar. Monitoring can avoid unnecessary procedures for lesions that appear low risk, but it is only safe when the clinician believes waiting is unlikely to compromise care and follow-up is reliable.

When a clinician is more likely to recommend biopsy

A clinician may recommend biopsy when a lesion has features that cannot be confidently explained as benign. This can include a new or changing pigmented spot, an asymmetrical mole, irregular borders, multiple colours, a lesion that is growing, or one that looks distinctly different from your other marks. The so-called “ugly duckling” sign matters because your usual mole pattern is part of the assessment.

A sore that does not heal, a scaly or thickened patch, a persistent crust, a bleeding spot or a tender lump may also require biopsy. Not all skin cancers are dark moles. Basal cell carcinomas can appear as pearly, pink or bleeding bumps. Squamous cell carcinomas may be rough, scaly, crusted or tender. Melanoma can develop in an existing mole or appear as a new mark, including on the soles, under nails and in areas that receive little sun.

A biopsy may be particularly appropriate if you have a previous melanoma or other skin cancer, a strong family history of melanoma, many moles, fair skin that burns easily, significant past sunburn or regular occupational sun exposure. Immune suppression can also increase skin cancer risk. These factors do not mean every spot is cancer, but they lower the threshold for acting decisively.

Symptoms deserve attention too. A spot that bleeds without being knocked, itches persistently, hurts, changes quickly or fails to settle should be assessed promptly. Do not wait for a planned annual skin check if a lesion is changing now.

What a skin biopsy may involve

The procedure is usually done under local anaesthetic in a clinic. Depending on the lesion and the question being asked, the doctor may remove the whole lesion, shave off a raised lesion, take a small punch sample or remove a narrow section. For a possible melanoma, clinicians generally aim to obtain a sample that allows the pathologist to assess the full depth of the lesion accurately.

The exact technique is a clinical decision. Location, size, appearance and the possibility of cancer all matter. You may need stitches, wound-care instructions and a follow-up appointment to discuss results. If cancer is confirmed, further treatment may be needed to ensure it has been completely removed.

The prospect of a scar can make people hesitant. That is understandable, especially on the face, chest or lower legs. But when cancer is a genuine possibility, a small scar is usually a safer trade-off than a delayed diagnosis. Your doctor can explain the likely scar, healing time and treatment options before proceeding.

When monitoring can be the right approach

Short-term digital monitoring can be useful for selected pigmented lesions that are not clearly cancerous but have a feature worth checking. By comparing high-quality dermoscopic images over a defined period, often around three months, a clinician can detect subtle changes that may not be visible to the naked eye.

Longer-term monitoring may be considered for people with numerous moles, particularly those with an elevated melanoma risk. It can help identify a new lesion or a lesion that changes differently from the rest. This is not a substitute for a full clinical examination. It is a tool that helps clinicians make more informed decisions and reduce unnecessary excisions where appropriate.

Monitoring is less suitable when a lesion is clearly suspicious, when symptoms are concerning, or when you may not be able to return on schedule. It also has limits in lesions that are difficult to photograph or assess, such as those on the scalp, between toes, under a nail or in areas affected by friction. In these situations, a clinician may favour biopsy or specialist assessment.

The key question is not whether a lesion can be watched. Almost any lesion can be watched. The question is whether watching it is medically safe.

Why home monitoring alone is not enough

Checking your own skin is valuable. It can help you notice changes between professional skin checks and prompt you to seek care earlier. But self-checking cannot replace a clinical assessment or a biopsy when one is indicated.

Mobile photos can be helpful to show a doctor when you first noticed a change, yet lighting, distance and image quality can be misleading. A lesion may look stable in a photo but reveal concerning structures under dermoscopy. Conversely, a harmless lesion can look alarming online. Avoid trying to diagnose a spot through internet images or comparing it with someone else’s mole.

If you have been advised to monitor a lesion, ask what exactly is being monitored, when you need to return and what changes should bring you back sooner. Write down the review date. If the spot changes, bleeds, becomes painful or worries you before that appointment, contact the clinic rather than waiting.

Questions to ask at your appointment

A good consultation should leave you clear about the plan. You may wish to ask whether the lesion is suspicious for melanoma, basal cell carcinoma or squamous cell carcinoma; why monitoring is considered safe if biopsy is not recommended; and how soon you should return.

If a biopsy is advised, ask what type will be performed, whether stitches are likely, when results will be available and who will contact you. It is reasonable to ask what happens if the pathology result is unclear or confirms skin cancer. Knowing the next step can make a confronting appointment feel more manageable.

If you remain concerned after reassurance, or if the lesion changes, seek a further clinical opinion. This is especially important for people at higher risk and for spots that do not fit your usual pattern.

Act on change, not reassurance from memory

Many people delay a skin check because the mark has been there “for ages”, because it comes and goes, or because they are reluctant to make a fuss. Skin cancers do not always follow a predictable pattern. A longstanding lesion can change, and a subtle new spot can be significant.

Make an appointment with a GP, skin cancer clinic or dermatologist if you have noticed a changing or unusual lesion. Tell the receptionist if it is bleeding, rapidly growing or a possible melanoma so the clinic can triage the appointment appropriately. If you have a previous melanoma or are under specialist surveillance, contact your treating team.

A biopsy is not a failure of monitoring, and monitoring is not a lesser form of care. Both are clinical tools. What matters is that the decision is based on a proper examination, your individual risk and a plan you understand. When a spot is changing, knowledge can save your life – arrange a professional skin check and let the evidence guide the next step.